During the past decade, PRA International Clinical Pharmacology Center (EDS US Clinic) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PRA International Clinical Pharmacology Center (EDS US Clinic)" are "Healthy Volunteer" (2 trials), "Autism Spectrum Disorder" (1 trials), "Healthy Participants" (1 trials) and "Healthy Volunteers" (1 trials). Many other conditions were trialed in "PRA International Clinical Pharmacology Center (EDS US Clinic)" in a lesser frequency.

Most popular intervention types in "PRA International Clinical Pharmacology Center (EDS US Clinic)" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials), "Placebo" (2 trials), "Active control [Moxifloxacin] on Day 15 Treatment D" (1 trials), "Active control [moxifloxacin] on Day 2 Treatment C" (1 trials) and "Balovaptan" (1 trials). Other intervention names were less common.

The vast majority of trials in "PRA International Clinical Pharmacology Center (EDS US Clinic)" are 5 trials for "All" genders.

Currently, there are NaN active trials in "PRA International Clinical Pharmacology Center (EDS US Clinic)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in PRA International Clinical Pharmacology Center (EDS US Clinic), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PRA International Clinical Pharmacology Center (EDS US Clinic), 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".